LLLucky Osaheni Lawani

Lucky Osaheni Lawani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lucky Osaheni Lawani has a total of 166 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Iron deficiency with and without anemia in pregnancy: A scoping review of prevalence and perinatal impact

    by Lucky O. Lawani, David M. Naimark, Joel G. Ray, Jessica Widdifield, Paul Eze, Chidumebi J. Idemili, Nadine Shehata

    Background: The prevalence of iron deficiency with anemia and iron deficiency without anemia (IDWA) during pregnancy have not been summarized, and evidence of the direct association of IDWA with adverse perinatal outcomes (APO) are unknown. Objectives: To summarize the prevalence of iron deficiency with and without anemia in pregnancy and determine if there is reported evidence of an effect for IDWA on adverse perinatal outcomes (APO). Search Strategy: Literature search was completed using four electronic databases, with no restrictions on date or language. Selection Criteria: Selected were observational studies, randomized controlled trials (RCTs), systematic reviews, meta‐analyses, narrative reviews on iron deficiency (ID) in pregnancy, published from inception to May 30, 2025. Data Collection and Analysis: Two independent reviewers screened article titles, abstracts, and full texts. The PRISMA guideline for scoping reviews was followed. A narrative summary was performed. Results: A total of 33 studies were included comprising five RCTs, 27 observational studies, and one narrative summary, involving 84 618 pregnant women. The prevalence of ID varied from 1.2%–71.0%; 1.2%–55.6% (IDA), and 1.6%–71.0% (IDWA). Two studies exclusively reported on IDWA and APO. The first study reported on preterm birth (adjusted odds ratio [aOR] 0.9, 95% confidence interval [CI]: 0.6–1.4), stillbirth (aOR 4.0, 95% CI: 1.0–14.3), low birthweight (aOR 0.6, 95% CI: 0.4–1.0), and small for gestational age (aOR 0.8, 95% CI: 0.5–1.2) in IDWA versus iron replete. The second study reported an adjusted birthweight of 3140 g (95% CI: 3067–3213) in IDWA and 3202 g (95% CI: 3164–3240) in iron replete individuals ( P = 0.16). Conclusions: Prevalence of ID varied widely, with substantial variability in biomarkers and diagnostic cut‐offs used in case definition. There were limited studies reporting on IDWA and its association with APO. Further research is needed to establish an association and to inform early screening and determine whether treating IDWA improves perinatal outcomes.


  • Open Access

    The Burden and Socioeconomic Inequality in Catastrophic Out-of-pocket Health Expenditure in Post-Pandemic Nigeria

    by Chioma Lynda Aniebo, Lucky Osaheni Lawani, Paul Eze

    Out-of-pocket (OOP) payments are the primary health financing mechanisms in Nigeria. This study—the first national analysis using post-COVID-19 data—examines the incidence and socioeconomic inequalities in catastrophic health expenditure (CHE) among Nigerian households using data from the nationally representative Nigeria General Household Survey 2023/2024. We estimated the proportion of households facing CHE using both household budget share (BS) and capacity-to-pay (CTP) approaches, with thresholds set at 10% and 40%, respectively. We assessed socioeconomic inequality in CHE incidence using the concentration index (CIX) and decomposed the CIX of CHE incidence using Wagstaff et al.’s (2003) approach. Our analysis show that households CHE incidence was 45.5% (95% CI: 43.5%–47.4%) and 43.1% (95% CI: 41.1%–45.0%) using the 10% BS and 40% CTP approaches, respectively. The Wagstaff-normalized CIX revealed pro-poor distributions of − 0.152 and − 0.178 for the BS and CTP approaches, respectively. Our decomposition analysis revealed that socioeconomic inequality in CHE was largely driven by female-headed households, larger households, households with elderly member(s), and rural residences. These findings indicate that OOP payments continue to impose a catastrophic financial burden on a substantial proportion of Nigerian households, particularly those with elderly individuals as well as female-headed, poor, large, and rural households. The intensity of these payments is also deeply impoverishing, highlighting the urgent need for targeted financial protection measures—such as the establishment of a comprehensive health insurance program for elderly Nigerians—to safeguard vulnerable populations and promote equitable access to healthcare.


  • Open Access

    Understanding Unmet Healthcare Needs in Nigeria: Implications for Universal Health Coverage

    by Paul Eze, Chioma Lynda Aniebo, Stanley Ilechukwu, Lucky Osaheni Lawani

    Background: Many individuals in low- and middle-income countries with healthcare needs do not access the necessary, often lifesaving healthcare services. Existing universal health coverage (UHC) indicators do not account for a portion of the population with unmet healthcare needs. Objective: To estimate the prevalence, wealth-related inequality, and determinants of unmet healthcare needs in Nigeria using data from the nationally-representative Nigeria Living Standards Survey, 2018-2019. Methods: We analyzed data from a cross-sectional sample of 116 320 Nigerians from 22 110 households selected using multi-stage probability sampling. The outcome variable was self-reported unmet healthcare needs. We conducted concentration index (CIX) analyzes to assess wealth-related inequalities and performed multilevel logistic regression analysis to identify the determinants of unmet healthcare needs at the individual, household, and community levels. Results: The prevalence of unmet healthcare needs was 5.2% (95% CI: 5.0-5.5), representing about 11 million Nigerians (95% CI: 10.5-11.5 million). The most common reasons were high costs (unaffordability) and the perception that the illness or injury was not serious. Wagstaff-normalized CIX for unmet healthcare needs was pro-poor: −0.09730 for the general population and −0.10878 for those with chronic illnesses. Significant determinants of unmet healthcare needs include age (AOR: 0.99, 95% CI: 0.99-1.00), chronic illness (AOR: 8.73, 95% CI: 7.99-9.55), single-person households (AOR: 1.55, 95% CI: 1.20-2.02), poorest quintile households (AOR: 1.45, 95% CI: 1.19-1.78), and mildly (AOR: 1.17, 95% CI: 1.01-1.36) or moderately food-insecure households (AOR: 1.30, 95% CI: 1.11-1.51). Conclusion: A significant proportion of Nigerians, particularly the very poor, chronically ill, those living alone, or food insecure, have unmet healthcare needs. This highlights the necessity for targeted interventions to ensure vulnerable populations can access essential healthcare services. To progress toward UHC, the Nigerian health system must address critical issues related to healthcare accessibility.


  • Open Access

    Epidemic preparedness and response capacity against infectious disease outbreaks in 186 countries, 2018–2022

    by Paul Eze, Judith Chidumebi Idemili, Friday Onwubiko Nwoko, Nigel James, Lucky Osaheni Lawani

    Disruptive public health risks and events, including infectious disease outbreaks, are inevitable, but their effects can be mitigated by investing in prevention and preparedness. We assessed the epidemic preparedness and response capacities of health systems in 186 countries from 2018 to 2022. We utilized data from the International Health Regulations (IHR) State Party Self-Assessment Annual Reporting (SPAR) submissions to assess health systems’ IHR capacities to (1) prevent, (2) detect, (3) respond, (4) enable resources and coordinate, and (5) ensure operational readiness from 2018 to 2022. We categorized the IHR capacities into five levels, with level 1 denoting the lowest level of national capacity and level 5 the highest. We calculated each index’s capacity level as the arithmetic mean of its related indicators and analyzed changes over time using the Mann–Kendall nonparametric trend test. SPAR reporting marginally improved from 92.9% (182 of 196 countries) in 2018 to 94.9% (186 of 196 countries) in 2022, with considerable improvement in all five capacity domains over this period: prevention (58.4 in 2018 to 66.5 in 2022), detection (74.7 to 78.3), response (56.5 to 67.8), enabling resources and coordination (63.0 to 68.3), and ensuring operational readiness (62.8 to 69.9). From the 2022 submissions, 116 (62%) countries reported functional (Level 4 or 5) prevention capacity, 162 (87%) had functional detection capacity, 118 (63%) had functional response capacity, 121 (65%) had functional enabling resources and coordination capacity, and 133 (72%) had functional operational readiness against public health events. Across all the indexes, the WHO African Region reported the fewest countries with functional capacity in these domains. There was an overall increase in functional capacity across all five domains at both global and regional levels; and a high percentage of countries achieved functional capacity across all domains in 2022. However, a significant number of countries, particularly in the Global South, have yet to achieve functional competence in these capacities, leaving the world vulnerable to the persistent risk of epidemics and infectious biohazards. Strengthening IHR competencies through local, national, and global engagements must be urgently prioritized to achieve global health security against infectious diseases.


  • Open Access

    Epidemic preparedness and response capacity against infectious disease outbreaks in 186 countries

    by Paul Eze, Judith Chidumebi Idemili, Friday Onwubiko Nwoko, Nigel James, Lucky Osaheni Lawani

    Objectives Disruptive public health risks and events, including infectious disease outbreaks, are inevitable, but their effects can be mitigated by investing in prevention and preparedness. We assessed the epidemic preparedness and response capacity of health systems in 186 countries from 2018 to 2022. Methods We utilized data from the International Health Regulations (IHR) State Party Self-Assessment Annual Reporting (SPAR) submissions to assess health systems’ IHR capacity to (1) prevent, (2) detect, (3) respond, (4) enabling function, and (5) operational readiness from 2018 to 2022. We categorized the IHR capacities into five levels, with level 1 denoting the lowest level of national capacity and level 5 denoting the highest. Results SPAR reporting marginally improved from 92.9% (182 of 196 state parties) in 2018 to 94.9% (186 of 196 state parties) in 2022, with considerable improvement in all five capacity domains over this period, especially in terms of the capacity to prevent and detect epidemic risks. Among the most recent (2022) submissions, 116 (63%) countries demonstrated functional prevention capacity (level 4 or 5), 162 (87%) had functional detection capacity, 118 (64%) had high response capacity, 121 (65%) had functional levels of resources and coordination, and 133 (71%) had the highest operational readiness against public health risks/events. Across all the indexes, the WHO African Region reported the fewest countries with functional capacity in these domains. Conclusions The world remains vulnerable to the persisting risk of epidemics and infectious biohazards, with wide variations among countries in their capacity to prevent, detect, and effectively respond to outbreaks. Strengthening IHR competencies through local, national, and global engagements must be urgently prioritized and funded to achieve global health security against infectious diseases.

  • Top Cited Papers
    Open Access

    Impact of community-based health insurance in low- and middle-income countries: A systematic review and meta-analysis

    by Paul Eze, Stanley Ilechukwu, Lucky Osaheni Lawani

    Background: To systematically evaluate the empirical evidence on the impact of community-based health insurance (CBHI) on healthcare utilization and financial risk protection in low- and middle-income countries (LMIC). Methods: We searched PubMed, CINAHL, Cochrane CENTRAL, CNKI, PsycINFO, Scopus, WHO Global Index Medicus, and Web of Science including grey literature, Google Scholar®, and citation tracking for randomized controlled trials (RCTs), non-RCTs, and quasi-experimental studies that evaluated the impact of CBHI schemes on healthcare utilization and financial risk protection in LMICs. We assessed the risk of bias using Cochrane’s Risk of Bias 2.0 and Risk of Bias in Non-randomized Studies of Interventions tools for RCTs and quasi/non-RCTs, respectively. We also performed a narrative synthesis of all included studies and meta-analyses of comparable studies using random-effects models. We pre-registered our study protocol on PROSPERO: CRD42022362796. Results: We identified 61 articles: 49 peer-reviewed publications, 10 working papers, 1 preprint, and 1 graduate dissertation covering a total of 221,568 households (1,012,542 persons) across 20 LMICs. Overall, CBHI schemes in LMICs substantially improved healthcare utilization, especially outpatient services, and improved financial risk protection in 24 out of 43 studies. Pooled estimates showed that insured households had higher odds of healthcare utilization (AOR = 1.60, 95% CI: 1.04–2.47), use of outpatient health services (AOR = 1.58, 95% CI: 1.22–2.05), and health facility delivery (AOR = 2.21, 95% CI: 1.61–3.02), but insignificant increase in inpatient hospitalization (AOR = 1.53, 95% CI: 0.74–3.14). The insured households had lower out-of-pocket health expenditure (AOR = 0.94, 95% CI: 0.92–0.97), lower incidence of catastrophic health expenditure at 10% total household expenditure (AOR = 0.69, 95% CI: 0.54–0.88), and 40% non-food expenditure (AOR = 0.72, 95% CI: 0.54–0.96). The main limitations of our study are the limited data available for meta-analyses and high heterogeneity persisted in subgroup and sensitivity analyses. Conclusions: Our study shows that CBHI generally improves healthcare utilization but inconsistently delivers financial protection from health expenditure shocks. With pragmatic context-specific policies and operational modifications, CBHI could be a promising mechanism for achieving universal health coverage (UHC) in LMICs.


  • Open Access

    Fetal and maternal outcome of higher-order multiple pregnancies in a tertiary hospital: A 5-year single-center observational study from Nigeria

    by Emmanuel I Ogumu, Chidebe Christian Anikwe, Bartholomew C Okorochukwu, Osita S Umeononihu, Basil I Nwokoye, Okoroafor F Chigozie, Chukwuemeka J Ofojebe, Lucky O Lawani

    Objective: The aim of this study was to determine the pattern and outcomes of higher-order multiple pregnancies in a tertiary hospital in Nigeria Methods: This is a retrospective review of all cases of higher-order multiple pregnancies that were managed between 1 January 2012 and 31 December 2016 in Alex Ekwueme Federal University Teaching Hospital Abakaliki, Nigeria. Data obtained were represented with frequency tables, percentages, bar charts, and odds ratio. Results: There were 22 higher-order multiple pregnancies over the study period and 12,002 deliveries, giving a higher-order multiple prevalence rate of 0.2%. Five of the mothers (four triplets and one quadruplet) had in vitro fertilization (0.4 per 1000 deliveries), while other mothers conceived naturally. Many of the women (12, 54.6%) were in the 30–34 years age group, and more than half (16, 72.7%) were multiparas. More than half of the neonates were delivered preterm (13, 59.1%). Being booked is associated with better neonatal outcomes although not significant (odds ratio = 3.06. 95% confidence interval: 0.55–16.83, p = 0.197). Anemia was common in the antepartum and postpartum periods. Half of the women (11, 50%) were delivered by elective cesarean section and 7 (31.8%) by emergency cesarean section (C/S), while 4 (18.2%) had a spontaneous vaginal delivery. The neonates had a mean birth weight of 2.14 ± 0.35 kg. Overall, 61 neonates (91.0%) were born alive and 6 (9.0%) suffered perinatal deaths, giving a perinatal mortality rate of 89.8 neonates per 1000 live births. Conclusion: Our study shows that higher-order multiple pregnancies are high-risk pregnancies that are associated with fetal and maternal complications. Anemia is the commonest complication seen in our study. The majority had preterm delivery. Proper antenatal care and close feto-maternal monitoring are important in reducing adverse outcomes associated with these pregnancies.


  • Open Access

    Tranexamic acid for reducing blood loss following vaginal delivery: a double-blind randomized controlled trial

    by Francis Nwabueze Igboke, Vitus Okwuchukwu Obi, Benedict Ikechukwu Dimejesi, Lucky Osaheni Lawani

    Background: Postpartum haemorrhage (PPH) is a major cause of maternal morbidity and mortality worldwide. Tranexamic acid (TXA) is a useful drug for prevention of PPH and merits evaluation in Nigeria, where PPH is the leading cause of maternal death (25%) and severe maternal morbidity. This study evaluates the efficacy of TXA in reducing blood loss following vaginal delivery. Methods: This was a double-blind randomized placebo-controlled study on the efficacy and safety of intravenous TXA in reducing blood loss in women undergoing vaginal delivery in a tertiary hospital. Data analysis was conducted with IBM SPSS software (version 20, Chicago II, USA). P-value < 0.05 was considered statistically significant. Results: The mean estimated blood loss was lower in TXA compared with the placebo group. (174.87 ± 119.83 ml versus 341.07 ± 67.97 ml respectively; P < 0.0001). PPH (blood loss > 500 ml) was 5.13% in the study arm compared to the control arm 7.14%- risk ratio (RR) 0.71; 95% CI: 0.38–1.79, p = 0.5956]. Additional uterotonics was required more in the control group compared to the treatment group 14(16.67%) versus 3(3.85%), p-value= 0.007. There were no major complications noticed in the treatment group. Conclusion: This study demonstrated that intravenous administration of TXA reduced blood loss following vaginal delivery. It also reduced the need for additional uterotonics. However, blood loss greater than 500 was not significantly reduced. Trial registration: This trial was registered retrospectively. Pan African Clinical Trial Registry: PACTR202010828881019 on 12/10/2020.


  • A community-based assessment of the perception and involvement of male partners in maternity care in Benin-City, Nigeria

    by Julie Osarenokemen Erhabor, Eugene Okpere, Lucky Osaheni Lawani, Eghosasere Sunday Omozuwa, Paul Eze

    Male involvement in maternal health promotion is paramount to safe motherhood. This study evaluates the perception and participation of male partners in maternity care (MC). A cross-sectional study involving 372 participants was conducted through qualitative (interviews and focus group discussion) and quantitative research methods which assessed knowledge, attitude and perception, between 1 December 2017 and 21 January 2018. The data were analysed with IBM SPSS version 25.0 using descriptive and inferential statistics. The mean age of the participants was 35.9 +/- 11.5 years. Four-fifths (80.4%) had a positive attitude towards MC but only 27.2% was actively involved, due to socio-cultural reasons. Knowledge regarding MC was associated with age (p = .023), employment (p = .039) and education (p = .002) - higher among younger-aged professionals with a higher education. Male partners had a positive attitude towards MC but were poorly involved, due to socio-cultural factors. Community health workers and stakeholders should step up community health education with engagement of men to promote their involvement.Impact statement What is already known on this subject?The role of men in maternity care (MC) is well defined and found to improve health outcomes in high income countries. However, their level of participation in a low income country, such as Nigeria, is far below expectation. What do the results of this study add?The result of this work has provided scarce community-based local data on male partners' involvement in MC. This study showed that majority of males demonstrated a positive attitude but were poorly involved, due to socio-cultural reasons. It also shown that those with a younger age, professionals and those with a higher education were more knowledgeable about MC. This suggests the need for health workers and key players to step up community health education and engagement of men to promote active involvement in women's health matters. What are the implications of these findings for clinical practice and/or further research?Stakeholders in low resource-settings like Nigeria could introduce interventions to scaling up health education, create the enabling hospital environment to accommodate male partners, actively engage, support and motivate them to be involved in MC. Further research will be required to assess the impact of such interventions and how to sustain potential benefits.


  • Open Access

    Perception and attitudinal factors contributing to periodic deworming of preschool children in an urban slum, Nigeria

    by Paul Eze, Ujunwa Justina Agu, Chioma Lynda Aniebo, Sergius Alex Agu, Lucky Osaheni Lawani

    Background: Over 20 million preschool-age children (PSAC) in Nigeria require periodic chemotherapy (PC) for soil-transmitted helminth (STH) infections. Persistently low coverage for this age group threatens the World Health Organization (WHO) 2030 target for eliminating STH infections. Current strategies for targeting PSAC have been largely ineffective. Hence, PSAC are mostly dewormed by their parents/caregivers. However, little is known of the perception and attitude of parents/caregivers of PSAC to deworming in this setting. Methods: A mixed methods design, combining a community-based interviewer-administered questionnaire-survey (n = 433) and focus group discussions (FGD) (n = 43) was used to assess the perceptions and attitudes of mothers to periodic deworming of preschool children aged 2–5 years in Abakpa-Nike, Enugu, Nigeria. Results: Coverage of periodic deworming in PSAC is 42% (95% CI: 37.3–46.8%). There is significant difference in the specific knowledge of transmission of STH (AOR = 0.62, 95% CI: 0.48–0.81, p = 0.000), complication of STH infections (AOR = 0.77, 95% CI: 0.61–0.98, p = 0.034), accurate knowledge of deworming frequency (AOR = 0.41, 95% CI: 0.18–0.90, p = 0.026), and knowledge of PC drug, mebendazole (AOR = 0.28, 95% CI: 0.09–0.90, p = 0.031), and pyrantel (AOR = 8.03, 95% CI: 2.22–29.03, p = 0.001) between mothers who periodically deworm their PSAC and those who do not. There is no significant difference in specific knowledge of the symptoms of STH infections (AOR = 0.76, 95% CI: 0.57–1.02, p = 0.069) and PC drug, Albendazole (AOR = 1.00, 95% CI: 0.46–2.11, p = 0.972). FGD revealed misconceptions that are rooted in stark ignorance of the disease. Overall attitude to deworming is positive and favourable. Conclusions: Poor coverage of periodic deworming for STH infections in PSAC in this setting are primarily driven by poor specific knowledge of the risks and burden of the infection. Focused health education on the burden and transmission of STH infections could complement existing strategies to improve periodic deworming of PSAC in this setting.